Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosis

Fernández Codina, Andreu; Nevskaya, Tatiana; Baron, Murray; Appleton, Christopher Thomas; Cecchini, Matthew; Philip, Amanda

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Fernández Codina, Andreu
dc.contributor.author	Nevskaya, Tatiana
dc.contributor.author	Baron, Murray
dc.contributor.author	Appleton, Christopher Thomas
dc.contributor.author	Cecchini, Matthew
dc.contributor.author	Philip, Amanda
dc.date.accessioned	2025-03-11T08:58:34Z
dc.date.available	2025-03-11T08:58:34Z
dc.date.issued	2025-02
dc.identifier.citation	Fernández-Codina A, Nevskaya T, Baron M, Appleton CT, Cecchini MJ, Philip A, et al. Brentuximab vedotin compared to historical controls for severe skin involvement in cutaneous systemic sclerosis. Rheumatology. 2025 Feb;64(2):888–9.
dc.identifier.issn	1462-0332
dc.identifier.uri	http://hdl.handle.net/11351/12737
dc.description	Afectación cutánea; Esclerosis sistémica cutánea
dc.language.iso	eng
dc.publisher	Oxford University Press
dc.relation.ispartofseries	Rheumatology;64(2)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Anticossos monoclonals - Ús terapèutic
dc.subject	Avaluació de resultats (Assistència sanitària)
dc.subject	Esclerodèrmia - Tractament
dc.subject	Medicaments immunosupressors - Tractament
dc.subject.mesh	Scleroderma, Systemic
dc.subject.mesh	/drug therapy
dc.subject.mesh	Immunosuppressive Agents
dc.subject.mesh	/therapeutic use
dc.subject.mesh	Treatment Outcome
dc.title	Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosis
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1093/rheumatology/keae460
dc.subject.decs	esclerodermia sistémica
dc.subject.decs	/farmacoterapia
dc.subject.decs	inmunosupresores
dc.subject.decs	/uso terapéutico
dc.subject.decs	resultado del tratamiento
dc.relation.publishversion	https://doi.org/10.1093/rheumatology/keae460
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Fernández-Codina A] Division of Rheumatology, Western University, London, ON, Canada. Division of General Internal Medicine-Windsor Campus, Western University, London, ON, Canada. Grup de Recerca de Reumatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Nevskaya T, Appleton CT, Philip A] Division of Rheumatology, Western University, London, ON, Canada. [Baron M] Division of Rheumatology, Jewish General Hospital, McGill University, Montreal, QC, Canada. [Cecchini MJ] Division of Pathology, Western University, London, ON, Canada
dc.identifier.pmid	39189988
dc.identifier.wos	001328852800001
dc.rights.accessrights	info:eu-repo/semantics/openAccess